BIIB Biogen Inc. | US09062X1037
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 29.850.748.928 | 27.059.508.270,26 | 25.835.332.806,4 | 20.549.736.268,62 |
| Enterprise Value | 32.129.949.696 | 30.238.708.270,26 | 29.404.032.806,4 | 23.277.036.268,62 |
| Trailing P/E | 21,74 | 19,72 | 19,98 | 15,32 |
| Forward P/E | 12,32 | - | - | - |
| Price to Sales | 3 | 2,72 | 2,61 | 2,7 |
| Price to Book | 1,6 | 1,45 | 1,42 | 1,13 |
| EV/Revenue | 3,23 | 3,04 | 2,97 | 3,06 |
| EV/EBITDA | 9,08 | 9,25 | 8,64 | 8,42 |